Heart transplantation remains the gold standard therapy for patients with advanced heart
failure; however, the utilization of heart transplantation is constrained by the limited supply of …

Background the incidence of organ donation after circulatory death (DCD) is increasing;
however, heart use has lagged behind other solid organs. Ex vivo perfusion devices are …

Heart transplantation remains the gold-standard therapy for end-stage heart failure; the
expected median survival range is 12–13 years. More than 30,000 heart transplants have …

Objectives Heart donation after circulatory death was recently reintroduced in the United
States with hopes of increasing donor heart availability. We examined its national use and …

Fifty years since the first successful human heart transplant from a non-heart beating donor,
this concept of heart transplantation from donation after circulatory determined death (DCD) …

Heart transplantation from donation after circulatory death (DCD) donors is a rapidly
expanding practice. In this review, we describe the history and challenges of DCD heart …

Heart transplantation remains the only definite treatment option for end‐stage heart
diseases. The use of hearts procured after donation after circulatory death (DCD) could help …

BACKGROUND In an effort to address the increasing demand for heart transplantation
within the United Kingdom (UK), we established a clinical program of heart transplantation …

Despite advances in mechanical support, heart transplantation still remains the gold
standard treatment for end-stage drugresistant heart failure. It provides both excellent long …

The first successful human heart transplantation was reported on 3 December 1967, by
Christiaan Barnard in South Africa. Since then this life‐saving procedure has been …